Here, we will provide an overview of one immunotherapeutic approach that utilizes a specialized vector to deliver the cDNA encoding the alternate reading frame (ARF; p14ARF in humans and p19Arf in mice) and IFNβ proteins to cancer cells. This evidence concerns the gene CDKN2A and cancer.